The sixth in our DIA DIRECT: COVID-19 Webinar Series will focus on the development of vaccines for COVID-19. Several potential COVID-19 vaccines are currently in the development pipeline, each providing either passive or active immunity to SARS-CoV-2 via different immunological mechanisms. Join us on Tuesday, June 2, at 9:00AM ET for DIA DIRECT: Developing Vaccines for COVID-19, for answers to these questions:
- How do these vaccines work? What is their mechanism of action?
- How do we advance promising therapies through pre-clinical testing and then ensure fast, efficient testing in the clinical setting?
- What is the most likely timeline for a COVID-19 vaccine from R&D to market access?
- Most of these therapies will reach the market via accelerated regulatory pathways with limited evidence of efficacy.
- How do we ensure that they remain safe and effective?
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.